Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries;Incidencia de trombosis venosa profunda y embolismo pulmonar en pacientes estadounidesenses intra y extra hospitalarios tras someterse a determinadas cirugías de riesgo

Annals of Pharmacotherapy

Volumn 45, Issue 9, 2011, Pages 1045-1052

  Amin, Alpesh N ^a   Lin, Jay ^b   Thompson, Stephen ^c   Wiederkehr, Daniel ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Novosys Health   (United States)

^c SANOFI   (France)

^d IQVIA   (United States)

Author keywords

Abdominal surgery; Continuum of care; Deep vein thrombosis; Orthopedic surgery; Pulmonary embolism; Thromboprophylaxis

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ABDOMINAL SURGERY; ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CLINICAL PRACTICE; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; EVIDENCE BASED PRACTICE; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MANAGED CARE; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; OUTPATIENT; PATIENT CARE; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; DATABASES, FACTUAL; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; OUTPATIENTS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; UNITED STATES; VENOUS THROMBOSIS;

EID: 80052441189     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q049     Document Type: Article

References (22)

1. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007;82:777-782. DOI 10.1002/ajh.20983
2. Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. J Thromb Thrombolysis 2009;28:458-464. DOI 10.1007/s11239-009-0351-1
3. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl): 381S-453S. DOI 10.1378/chest.08-0656
4. Kakkar AK, Cohen AT, Tapson VF, et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg 2010;251:330-338. DOI 10.1097/SLA.0b013e3181c0e58f
5. Amin AN, Stemkowski S, Lin J, Yang G. Inpatient thromboprophylaxis use in US hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med 2009;4:E15-E21. DOI 10.1002/jhm.526
6. Amin A, Spyropoulos AC, Dobesh P, et al. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE Start). J Thromb Thrombolysis 2010;29:326-339. DOI 10.1007/s11239-009-0361-z
7. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007;64:69-76.
8. Rahme E, Dasgupta K, Burman M, et al. Postdischarge thromboprophylaxis and mortality risk after hipor knee-replacement surgery. CMAJ 2008;178:1545-1554. DOI 10.1503/cmaj.071388
9. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-394. DOI 10.1016/S0140-6736(08)60202-0
10. Muntz J. Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues. Am J Surg 2010;200:413-421. DOI 10.1016/j.amjsurg.2009.05.045
11. Anderson FA Jr, Hirsh J, White K, Fitzgerald RH Jr; Hip and Knee Registry Investigators. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 2003;124(6 Suppl):349S-356S. DOI 10.1378/chest.124.6_suppl.349S
12. Surgical Care Improvement Project (SCIP). Colorado Foundation for Medical Care. http://www.cfmc.org/hospital/hospital_scip.htm (accessed 2011 Jan 24).
13. US Department for Health & Human Services. Centers for Medicare & Medicaid Services. Reporting hospital quality data for annual payment update. Last updated 9/2010. http://www.cms.hhs.gov/HospitalQualityInits/08_HospitalRHQDAPU.asp (accessed 2011 Jan 24).
14. US Department for Health & Human Services. Centers for Medicare & Medicaid Services. Hospital-acquired conditions. Last updated 12/2010. http://www.cms.hhs.gov/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp (accessed 2011 Jan 24).
15. Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. JAMA 2009;301:1063-1065. DOI 10.1001/jama.301.10.1063
16. The Joint Commission. Venous thromboembolism (VTE) core measures set. http://www.jointcommission.org/assets/1/6/Venous%20Thromboembolism.pdf (accessed 2011 Jan 24).
17. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007;167:1471-1475.
18. Huo MH, Muntz J. Extended thromboprophylaxis with low-molecularweight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin Ther 2009;31:1129-1141. DOI 10.1016/j.clinthera.2009.06.002
19. Rasmussen MS, Jørgensen LN, Wille-Jørgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2009;(1):CD004318. DOI 10.1002/14651858.CD004318.pub2
20. Merli GJ, Malangone E, Lin J, Lamerato L, Stern L. Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database. J Thromb Thrombolysis 2011 July;32:89-95. DOI 10.1007/s11239-011-0554-0
21. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358:9-15. DOI 10.1016/S0140-6736(00)05249-1
22. Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy 2004;24: 953-963. DOI 10.1592/phco.24.11.953.36133